EGFR and non-small cell lung carcinoma: Examples include testing for epidermal growth factor receptor (EGFR) to determine the use of erlotinib in advanced nonsmall cell lung cancer (NSCLC), and KRAS testing to determine the use of cetuximab in advanced colorectal cancer.